• Antithrombin III deficiency (abbreviated ATIII deficiency) is a deficiency of antithrombin III. (wikipedia.org)
  • Hereditary antithrombin deficiency results in a state of increased coagulation which may lead to venous thrombosis. (wikipedia.org)
  • The causes of acquired antithrombin deficiency are easier to find than the hereditary deficiency. (wikipedia.org)
  • The prevalence of antithrombin deficiency is estimated at ~0.02 to 0.2% of the general population, and 1-5% of patients with venous thromboembolism. (wikipedia.org)
  • There is an elevated risk of thrombosis, whereby 50% patients with AT deficiency were found to have venous thromboembolism by age 50. (wikipedia.org)
  • A clinical suspicion for antithrombin deficiency can be made in patients with: 1. (wikipedia.org)
  • In patients with antithrombin deficiency, they may develop resistance to unfractionated heparin, especially with continuous infusions. (wikipedia.org)
  • Functional assays that assess inhibitory activity on Xa have a higher sensitivity than those assessing thrombin, and some patients with type II AT deficiency have only slightly reduced or even normal function, thus increasing the complexity of its diagnosis. (medscape.com)
  • When patients with a known inherited AT deficiency experience an acute thrombotic event and fail to respond to intravenous heparin, treatment with a direct thrombin inhibitor (eg, argatroban, dabigatran) is recommended. (medscape.com)
  • In 1965, Olav Egeberg described the first family with thrombotic disease due to inherited antithrombin deficiency, providing convincing evidence of the clinical importance of antithrombin. (medscape.com)
  • Clinical applications include management of patients with hereditary antithrombin III (AT-III) deficiency. (hemonc.org)
  • Antithrombin III (ATIII) deficiency is most commonly associated with venous thrombosis. (medscape.com)
  • Often, children with antithrombin III deficiency present with unusual clot locations (eg, mesenteric veins, splenic veins). (medscape.com)
  • although little is known of the impact of ABO phenotype on more severe procoagulant conditions like antithrombin deficiency, the ABO phenotype should be documented. (medscape.com)
  • Patients with congenital antithrombin III deficiency who have had one unprovoked thrombotic event (particularly in the mesenteric or splanchnic systems) are much more likely to have recurrent clots. (medscape.com)
  • No physical stigmata are associated with congenital antithrombin III deficiency. (medscape.com)
  • Acquired antithrombin III deficiency is usually due to abnormal activation of a coagulation pathway or synthetic defect, often from medication (eg, L-asparaginase) or liver disease. (medscape.com)
  • Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. (medscape.com)
  • Di Minno MN, Dentali F, Lupoli R, Ageno W. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study. (medscape.com)
  • Thus, although the antithrombin III deficiency in fulminant hepatic failure can be corrected by supplementation with antithrombin III concentrate, its use in the prevention of intravascular coagulation and to avoid microvessel plugging needs to be studied at an earlier stage in the disease. (uea.ac.uk)
  • The measurement of antithrombin activity (functional antithrombin level) is a widely used laboratory test in clinical practice, while the antithrombin antigen (immunological antithrombin level) assay, which is used to confirm inherited antithrombin deficiency only, is rarely used. (medscape.com)
  • Inherited antithrombin deficiency is less common than acquired deficiency. (medscape.com)
  • [ 3 ] The diagnosis of hereditary deficiency requires testing of both antithrombin activity and antithrombin antigen, and repeated testing and family studies may be needed. (medscape.com)
  • Antithrombin deficiency can increase the risk of recurrent miscarriage. (medscape.com)
  • Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options. (medscape.com)
  • For example, hemostatic levels of factor IX in a patient with severe deficiency are difficult to achieve with FFP alone, whereas patients with severe factor X deficiency require factor levels of about 10 percent to achieve hemostasis and are easily treated with FFP. (openanesthesia.org)
  • The peculiarities of our observations reside in the occurrence of the disease in a man and that it was a manifestation of even less frequent condition such as Inferior vena cava agenesis and Antithrombin III deficiency. (isth.org)
  • 12. Subjects with a history of hypercoagulable disorders such as protein S or C deficiency, Factor 5 Leiden resistance, Antithrombin III deficiency, Antiphospholipid antibody syndrome, Heparin Induced Thrombocytopenia etc. (who.int)
  • Diagnostic challenge of the newborn patients with heritable protein C deficiency. (cdc.gov)
  • Aortic Mural Thrombus Associated with Congenital Protein C Deficiency in an Elderly Patient. (cdc.gov)
  • Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State. (cdc.gov)
  • Pregnancy-related thrombosis risk in patients with protein C deficiency and comparison with pregnant women with heterozygous factor V Leiden mutation. (cdc.gov)
  • We investigated the effects of hypoxia on indices of coagulation and systemic inflammation in patients with COPD. (nih.gov)
  • This study demonstrates that a 2-h hypoxic challenge in patients with COPD results in coagulation activation in conjunction with an increase in systemic inflammation. (nih.gov)
  • The purpose of this retrospective case-control study is to determine the effect of continuous antithrombin III (ATIII) infusion on extracorporeal membrane oxygenation (ECMO) coagulation. (umn.edu)
  • Patients with fulminant hepatic failure have severe circulatory disturbances which may be due to fibrin and cellular plugs in micro-vessels which are a consequence of intravascular coagulation and which can lead to multiorgan failure. (uea.ac.uk)
  • Since antithrombin III supplementation has been shown to be beneficial in animal models of septic shock with disseminated intravascular coagulation, a controlled study was performed to investigate the effect of antithrombin III supplementation in fulminant hepatic failure. (uea.ac.uk)
  • Twenty-five patients in grade III or IV coma were selected on the basis of evidence of sepsis, intravascular coagulation and a high risk of developing multiorgan failure. (uea.ac.uk)
  • Antithrombin III is a serum protease inhibitor that inhibits the blood coagulation protease, thrombin, and is an important regulator of hemostasis. (scrippslabs.com)
  • Conclusions: The levels of coagulation, fibrinolytic, and endothelial markers have been reported to be significantly higher in AF patients than in SR patients. (uni-koeln.de)
  • Antithrombin is a natural anticoagulant that inhibits the activated coagulation factors thrombin (factor IIa), factor Xa, and, to a lesser extent, factor XIa and factor IXa. (medscape.com)
  • The antithrombin level does not influence the results of screening coagulation tests such as partial thromboplastin time (PTT), prothrombin time (PT), and thrombin time. (medscape.com)
  • Although the clinical concept of hypercoagulability has been appreciated for decades, only since the 1980s has it been possible to identify an underlying disorder of coagulation in a subset of patients with thrombosis. (medlink.com)
  • Patients who are anticoagulated with warfarin are deficient in the functional vitamin K dependent coagulation factors II, VII, IX, and X, as well as proteins C and S. These functional deficiencies can be reversed by the administration of vitamin K. However, for anticoagulated patients who are actively bleeding or who require emergency surgery, FFDP (or single-donor plasma) can be used to achieve immediate hemostasis. (openanesthesia.org)
  • Pathological hemorrhage in the massively transfused patient is caused more frequently by thrombocytopenia than by depletion of coagulation factors. (openanesthesia.org)
  • There is no evidence that the prophylactic administration of FFP decreases transfusion requirements in multiply transfused patients who do not have documented coagulation defects. (openanesthesia.org)
  • Material and methods: In study I, coagulation factor activities were measured before and after surgery in a cohort of 57 patients undergoing first time elective coronary artery bypass grafting (CABG). (5dok.org)
  • Type I, which is quantitative, results from heterozygous point mutations or major gene deletions leading to low antithrombin antigen and activity levels. (medscape.com)
  • Blood was sampled for thrombin-antithrombin complex (TAT), prothrombin activation fragments 1 + 2 (F(1 + 2)), von Willebrand factor antigen (VWF:Ag), D-dimer, and interleukin-6 (IL-6) at baseline and after 2 h. (nih.gov)
  • Initial and sequential levels of ATIII (activity), PC (antigen and activity), PS (total and free), and C4b binding protein (C4bBP) were compared according to the outcome in patients with DIC. (qxmd.com)
  • It is a rare hereditary disorder that generally comes to light when a patient suffers recurrent venous thrombosis and pulmonary embolism, and repetitive intrauterine fetal death (IUFD). (wikipedia.org)
  • childhood thrombosis, 3. (wikipedia.org)
  • For patient education information, see Deep Vein Thrombosis . (medscape.com)
  • Thus, even short periods of abnormal liver function may reduce antithrombin production, leading to potential thrombosis. (medscape.com)
  • Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter study. (bvsalud.org)
  • The association between thrombolytic therapy and the outcome in patients with portal vein thrombosis (PVT) remains controversial. (bvsalud.org)
  • I want to share my story because, most importantly, it was as a result of reading patient stories on the National Blood Clot Alliance website that I went to get checked and was diagnosed with a deep vein thrombosis (DVT) in my left calf. (stoptheclot.org)
  • However, due to a late onset of venous thrombosis and a relatively recent development of the ability to accurately screen for specific defects, many patients have family histories that are negative for the condition, even in affected kindreds. (medscape.com)
  • Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation. (medscape.com)
  • Elevated levels may be detected in patients with deep vein thrombosis and septicemia. (scrippslabs.com)
  • In this update, the author discusses advancements in the epidemiology, diagnosis, treatment, and prognosis of patients with arterial ischemic stroke and cerebral venous thrombosis associated with genetic and acquired thrombophilia, including the antiphospholipid antibody syndrome. (medlink.com)
  • The use of direct oral anticoagulants (DOACS) in the treatment of patients with cerebral venous thrombosis has been established by recent research. (medlink.com)
  • The clinical manifestations of thrombophilic patients can be due to either venous thrombosis or (rarely) arterial thrombosis. (medlink.com)
  • If a patient with venous thrombosis has a right-to-left shunt such as a patent foramen ovale or pulmonary arteriovenous malformation, an embolus may dislodge from the thrombus and pass through this shunt to cause an arterial ischemic stroke, termed a "paradoxical embolus. (medlink.com)
  • FFP can be used as a source of antithrombin III in patients who are deficient in this inhibitor and are undergoing surgery or who require heparin for treatment of thrombosis. (openanesthesia.org)
  • A-39-year-old male patient followed for acute articular rheumatism was hospitalized for thrombosis of the right thoraco-epigastric vein. (isth.org)
  • A 69-year-old patient with diabetes and hypertension was hospitalized for thrombosis of superior epigastric vein. (isth.org)
  • and (3) the compared pattern of sequential ATIII, PC, and PS levels according to clinical outcome. (qxmd.com)
  • In addition, clinical practice guidelines state NSAIDs should not be administered to patients presenting with and hospitalized for ST-elevation myocardial infarction (STEMI) due to increased risk of mortality, reinfarction, hypertension, heart failure, and myocardial rupture associated with their use. (pdr.net)
  • We present five patients with aneurysm and compare the clinical and pathologic findings with those of eight patients described in the literature. (neurology.org)
  • The exclusion of patients with clinical risk factors did not improve the detection rates, in comparison with those with obvious provoking clinical risk factors (11.72%, 95% CI 7.36 to 18.06 vs 11.29%, 95% CI 6.73 to 18.18). (bmj.com)
  • Over 100 free commonly used clinical formulas and calculator tools to help diagnose, treat, prevent, and determine prognosis of patients at point of care. (guidelinecentral.com)
  • Identify clinical preventive services that are appropriate for your patients. (guidelinecentral.com)
  • Clinical conditions associated with low levels of Antithrombin III are venous thromboembolism and liver disease. (scrippslabs.com)
  • We conducted a single-center, prospective, randomized clinical trial of adult, high-risk trauma patients admitted to a level 1 trauma center over a 2-year period. (dtic.mil)
  • An increased antithrombin level is not a clinical problem. (medscape.com)
  • The QRT was used to make initial PPV settings in 25 patients with iNPH and the clinical outcomes were evaluated. (go.jp)
  • Rinsho ketsueki] The Japanese journal of clinical hematology 2019 5 60 (3): 171-183. (cdc.gov)
  • 0.001) for patients with PAP <1000 μg/L and D-dimer >0.5 mg/L and 15.5 (CI95 2.8-87, p = 0.002) for patients with PAP <1000 μg/L and AT ˂0.85 kIU/L. We observed an elevated fraction of incompletely degraded D-dimer fragments in COVID-19+ patients with low PAP, indicating impaired fibrinolytic breakdown of cross-linked fibrin. (lu.se)
  • In both types of malaria, parasitemia correlated with blood levels of tumour necrosis factor alpha (TNF-alpha), lactate dehydrogenase (LDH), Thrombin-antithrombin III (TAT) and elastase, and these parameters were higher in P. falciparum malaria than in P. vivax or ovale malaria. (nih.gov)
  • previously referred to as antithrombin III) is a 58-kDa molecule belonging to the serine protease inhibitor (serpin) superfamily that plays a central role in anticoagulation and regulating appropriate wound healing in mammalian circulation systems. (medscape.com)
  • In performing noncardiac surgery on patients on anticoagulation, the major concern is when it is safe to perform surgery without increasing the risk of hemorrhage or increasing the risk of thromboembolism (eg, venous, arterial) after discontinuing treatment. (medscape.com)
  • The greatest problem encountered is that no consensus exists regarding the optimal perioperative management of anticoagulation for patients who have been receiving long-term warfarin therapy. (medscape.com)
  • Some prospective studies have suggested that patients on long-term warfarin therapy who undergo minor invasive procedures and are taken off their oral anticoagulation for up to 5 days have a less than 1% risk of experiencing a thromboembolic event. (medscape.com)
  • The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) study included 3007 patients with nonvalvular atrial fibrillation who were receiving long-term therapy with dabigatran, rivaroxaban, or apixaban. (medscape.com)
  • Study III is a prospective trial, randomizing 60 elective CABG or valve replacement surgery patients to either anticoagulation with weight-based heparin dosing or using heparin and protamine titration with a bedside device. (5dok.org)
  • In the group DIC+, all patients but two had severe deficiencies in ATIII and PC levels. (qxmd.com)
  • The initial ATIII level was the best laboratory predictor of death in these patients. (qxmd.com)
  • Only 28% of the historic controls receiving intermittent ATIII doses achieved normal ATIII activity as compared with 80% of study patients (p = 0.24). (umn.edu)
  • Demographic data, criteria of severity, mortality in ICU, frequency of organ failure, hemodynamic and oxygenation parameters, and laboratory findings were compared in patients with septic shock according to the occurrence of DIC. (qxmd.com)
  • In this single-center cohort study, we applied a panel of laboratory markers to characterize hemostatic function in 217 consecutive patients that underwent testing for COVID-19 as they were admitted to Linköping University Hospital between April and June 2020. (lu.se)
  • 2017. https://nursing.unboundmedicine.com/nursingcentral/view/Davis-Lab-and-Diagnostic-Tests/425209/all/Antithrombin. (unboundmedicine.com)
  • In COVID-19+ patients, we found pronounced increases in plasma levels of von Willebrand factor (vWF) and fibrinogen. (lu.se)
  • When thrombocytopenia is detected, tests of hemostasis (OSPT, APTT, FDP or D-dimer, fibrinogen, antithrombin III) are performed to determine if the patient has a disseminated intravascular coagulopathy (DIC). (ivis.org)
  • In study IV, plasma of 10 cardiac surgery patients was spiked with various concentrations of human plasma derived fibrinogen or recombinant human fibrinogen. (5dok.org)
  • Cryptococcosis is a well-recognised infection in immunocompromised patients, although its prevalence varies with the type of immune defect. (annals.edu.sg)
  • Method An unselected cohort of venous thromboembolism patients in three tertiary institutions in Singapore was prospectively tested for the prevalence of deficiencies of protein C, protein S, antithrombin III, factor V Leiden and prothrombin 20210 gene mutations. (bmj.com)
  • Patient need for Ig therapeutics is expected to rise, especially to treat the growing prevalence of immunodeficiencies, which account for approximately 40% to 55% of the total Ig market, according to the company. (ncmedsoc.org)
  • Only one patient was positive for the factor V Leiden mutation and none tested positive for the prothrombin 20210 gene mutation. (bmj.com)
  • The impact of antithrombin III activity AT-III and on prophylactic enoxaparin serum trough anti-factor Xa concentration anti-Xa has not been evaluated. (dtic.mil)
  • The empiric use of FFP to reverse hemostatic disorders should be confined to those patients in whom factor deficiencies are presumed to be the sole or principal derangement. (openanesthesia.org)
  • The normal plasma level is 150 mcg/mL and the plasma half-life is approximately 3 days. (medscape.com)
  • Plasma antithrombin is comprised of 432 amino acids, 6 of which are cysteine residues that form 3 intramolecular disulfide bonds. (medscape.com)
  • 3. Heparin treatment may lower plasma antithrombin. (mghlab.com)
  • Treatment with thrombin inhibitors may lead to overestimation of the antithrombin level in plasma. (medscape.com)
  • Purification and filling follows the fractionation of plasma into separate proteins, including Ig, alpha-1 proteinase inhibitor, albumin and antithrombin-III, each indicated for different conditions. (ncmedsoc.org)
  • viscosity, reduced red cell deformability, The main objectives of this study were abnormal red cell adhesive properties, en- to assess platelet aggregation patterns and dothelial intimal proliferation, bone marrow levels of PC, PS and AT III in SCA patients or fat embolism and a chronic hypercoagula- in the steady state and in vaso-occlusive ble state [6]. (who.int)
  • Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. (qxmd.com)
  • Acute cocaine toxicity has three reported phases. (medscape.com)
  • Evidence of previous episode(s) of acute venous thromboembolic episodes in patient history (prior to current admission). (outcomes-umassmed.org)
  • IMPROVE is an international observational database of outcomes for patients who are hospitalized for an acute medical illness. (outcomes-umassmed.org)
  • Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia. (cancercentrum.se)
  • Testing for specific mutations in these patients helps to determine the decision on the duration of anticoagulant therapy, risk stratification for primary or secondary prophylaxis. (intechopen.com)
  • Conclusions Our results suggest that high-dose corticosteroid treatment does not improve the prognosis of patients with ARDS, even in this era. (medscape.com)
  • Paul Morawitz at the University of Tubingen first coined the term antithrombin in 1905 to describe plasma's ability to neutralize thrombin activity. (medscape.com)
  • Antithrombin III activity increased from 0.26 +/- 0.04 SE U/ml to 0.82 +/- 0.07 U/ml at 3 h post infusion (normal range 0.80-1.20 U/ml) and remained greater than 0.80 U/ml throughout the study without any apparent increase in the frequency of bleeding. (uea.ac.uk)
  • The objective of this study was to determine if AT-III activity affects enoxaparin anti-Xa target attainment and to evaluate two enoxaparin dose adjustment strategies in patients with low anti-Xa concentrations. (dtic.mil)
  • Antithrombin activity is measured by synthetic chromogenic activity in the presence of excess heparin levels. (medscape.com)
  • Twenty clinically stable patients with mild COPD were recruited. (nih.gov)
  • SAN DIEGO, CA-Among ACS patients undergoing invasive management, the use of radial vs femoral access improves outcomes, driven by reductions in major bleeding and mortality, according to trial results from the MATRIX program. (tctmd.com)
  • As its name implies, antithrombin was first characterized as an inhibitor of thrombin. (medscape.com)
  • Coordinated serum AT-III, anti-Xa, and thromboeslastogram samples were drawn 8 hours after the third dose of enoxaparin. (dtic.mil)
  • Patients with a history volumes of blood were added to 1 volume of taking hydroxyurea were excluded from of sodium citrate (3.8%) for measurement the study. (who.int)
  • A high concentration of hemoglobin, bilirubin, and triglycerides might affect antithrombin measurement. (medscape.com)
  • Once a diagnosis of aneurysmal arteriopathy was made, the patients deteriorated rapidly, with death occurring in less than 6 months. (neurology.org)
  • NSAIDs may increase the risk of a cardiovascular thrombotic event in patients with or without underlying heart disease or risk factors for heart disease. (pdr.net)
  • The majority of patients can be treated on an outpatient basis, but if your dog is showing signs of severe nitrogenous waste in the bloodstream (azotemia), high blood pressure (hypertension), or blocked vessels due to clotting (thromboembolic disease), it should be hospitalized. (petmd.com)
  • In addition, normotensive patients receiving antihypertensive therapy had higher increases in blood pressure than subjects with uncontrolled hypertension or normotensive subjects receiving no hypertensive therapy. (pdr.net)
  • Seven patients acquired HIV infection perinatally, five patients were infected by blood transfusions, and one patient had both risk factors. (neurology.org)
  • Two of these proteins are albumin, which helps to maintain blood pressure and keep blood in the vessels, and antithrombin III, which prevents blood clots from forming. (petmd.com)
  • Wijeysundera et al sought to determine whether N-acetylcysteine is associated with increased blood loss and blood product transfusion in 89 patients with preexisting moderate renal insufficiency undergoing cardiac surgery. (medscape.com)
  • The investigators found patients in the N-acetylcysteine group had a 261-mL greater mean 24-hour chest-tube blood loss and received 1.6 units more of red blood cell transfusions than the placebo group. (medscape.com)
  • [ 1 ] In addition, there was a significantly higher risk of receiving 5 or more units of red blood cells within 24 hours of surgery in the patients receiving N-acetylcysteine compared with the placebo group ( P = 0.005). (medscape.com)
  • Various methods have been used to decrease blood loss and transfusion requirements in patients undergoing liver transplantation, with a view to improve the results of liver transplantation. (cochrane.org)
  • We performed a detailed review of the medical literature (available until September 2011) to determine the benefits and harms of different methods of decreasing blood loss and transfusion requirements in patients undergoing liver transplantation. (cochrane.org)
  • We are unable to advocate or refute any method of decreasing blood loss and transfusion requirements in patients undergoing liver transplantation. (cochrane.org)
  • It circulates in the blood, with a half-life of 2-3 days. (medscape.com)
  • The intermittent manual bolus thermodilution method is the most common means of determining cardiac output in critically ill patients. (annals.edu.sg)
  • As dentists, we are continually updating our knowledge about oral cancer, bacterial endocarditis, diabetes, cardiac disease and all the many ways they intertwine with what we are planning for our patients' oral health needs. (stoptheclot.org)
  • Cardiac complications constitute a major cause of postoperative morbidity and mortality in surgical patients. (medscape.com)
  • 1000 μg/L and AT ˂0.85 kIU/L. We observed an elevated fraction of incompletely degraded D-dimer fragments in COVID-19+ patients with low PAP, indicating impaired fibrinolytic breakdown of cross-linked fibrin. (lu.se)
  • Antithrombin concentrates have been used, though with risk of bleeding at large doses of unfractionated heparin. (wikipedia.org)
  • Patients with COPD are also at increased risk of VTE, particularly during exacerbations, possibly because of a hypercoagulable state secondary to hypoxia and/or heightened systemic inflammation. (nih.gov)
  • Patients with a history GI disease (e.g., peptic ulcer disease, GI bleeding) who use NSAIDs have a greater than 10-fold increased risk for developing a GI bleed compared to patients with neither of these risk factors. (pdr.net)
  • Consider therapies besides NSAIDs for high risk patients. (pdr.net)
  • Patients with known heart disease or risk factors appear to have a greater likelihood of an event following NSAID use, likely due to a higher baseline risk. (pdr.net)
  • Yilmaz S, Gunaydin S. Inherited risk factors in low-risk venous thromboembolism in patients under 45 years. (medscape.com)
  • Three independent case control studies have shown an increased risk od endometrial cancer in postmenopausal women exposed to exogenous estrogens for prolonged periods. (drugs.com)
  • 1-3 The risk was independent of other known risk factors for endometrial cancer. (drugs.com)
  • Although the evidence must be considered preliminary, one study suggests that cyclic administration in low doses of estrogen may carry less risk than continuos administration, 3 it therefore appears prudent to utilize such a regimen. (drugs.com)
  • When considering noncardiac surgery, these factors and the need to weigh the risk of hemorrhage against that of thromboembolism must be analyzed on an individual patient basis. (medscape.com)
  • The three case control studies reported that the risk of endometrial cancer in estrogen users was about 4.5 to 13.9 times greater than in nonusers. (rxlist.com)
  • However, these findings are based on few trials with a high risk of bias (systematic overestimation of benefits) and high risk of play of chance (random error due to small number of patients). (cochrane.org)
  • In addition, the optimal strategy for enoxaparin dose adjustment to attain target anti-Xa trough concentrations is unknown in high-risk trauma patients. (dtic.mil)
  • Patients were eligible for inclusion if prescribed enoxaparin 30 mg subcutaneously every 12 hours for venous thromboembolism chemoprophylaxis based on a Greenfield Risk Assessment Profile score of 5 or more. (dtic.mil)
  • The patient in question 1 has a minimal bradycardic effect and explains the high risk study. (lowerbricktown.com)
  • Evidence is inconsistent about whether CHC use affects fracture risk ( 34 - 45 ), although three recent studies show no effect ( 34 , 35 , 45 ). (cdc.gov)
  • this risk is most pronounced in the first 3 weeks after delivery, decreasing to near baseline levels by 42 days postpartum ( 90 - 94 ). (cdc.gov)
  • Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction. (cdc.gov)
  • Risk factors for venous thromboembolism (VTE) recurrences in Thai patients without cancer. (cdc.gov)
  • Thrombophilic risk factors in hemodialysis: Association with early vascular access occlusion and patient survival in long-term follow-up. (cdc.gov)
  • EEMT (esterified estrogens and methyltestosterone) is a combination of the female hormone estrogen and the male hormone testosterone used to treat moderate to severe vasomotor symptoms associated with menopause in those patients not improved by estrogens alone. (rxlist.com)
  • We report a case of ascending aortic thrombectomy in a patient with esophageal cancer who developed ascending aortic thrombus after starting neoadjuvant chemotherapy, including operative findings and surgical treatment. (springeropen.com)
  • The treatment strategy should depend on thrombus location and the condition of the patient, but surgical treatment should be considered where possible to achieve better prognosis. (springeropen.com)
  • Correcting AT levels using antithrombin concentrate products is recommended for planned major surgery. (medscape.com)
  • She was taking com- ase (MTHFR) point mutations [ 3 ]. (who.int)
  • Evaluation of etiology and pregnancy outcome in recurrent miscarriage patients. (cdc.gov)
  • In patients with DIC, a fatal outcome was associated with higher bilirubin and transaminase levels, lower PaO2/FIo2 ratio, Vo2, Do2 and O2 extraction. (qxmd.com)
  • Administration of full-dose unfractionated heparin (but not LMWH) can cause a reversible reduction in antithrombin levels of up to 30% within several days. (medscape.com)
  • Already the discovery of the first families presenting a defect in antithrombin (AT) led to the description of the genetic causes of this defect. (intechopen.com)
  • Fluid and electrolyte therapy all diabetic patients with symptomatic treatment followed by iv infusion. (lowerbricktown.com)
  • Results Among 384 patients screened, the prevalences of protein S, protein C and antithrombin III were 9.20%, 1.18% and 4.19% respectively. (bmj.com)
  • The results from this review do not reveal any increased mortality with aprotinin in the liver transplantation setting although one has to interpret this information with caution because of the few patients included in the trial. (cochrane.org)
  • Our results, in conjunction with the updated meta-analysis, suggest that [the] radial approach should become the default access for patients with ACS undergoing invasive management," Dr. Valgimigli said. (tctmd.com)
  • The mean PPV setting at 1 year after operation was 15.5 ± 3.9 cmH 2 O. Use of the QRT in non-bedridden iNPH patients results in a low incidence of PPV readjustment. (go.jp)
  • The patients tolerated this modified transsphenoethmoidal approach well and the postoperative results were satisfactory. (go.jp)
  • Although the number of patients was too small to allow any statistical analysis, the results, compared with other series, are encouraging. (go.jp)
  • If Estrapel is used during pregnancy, or if the patient becomes pregnant while taking this drug, she should be apprised of the potential risks to the fetus, and the advisability of pregnancy continuation. (drugs.com)
  • During this consultation, the patient can be advised about the possible risks associated with her condition during pregnancy and about the possible teratogenic effects of her medications. (medscape.com)
  • Neutrophilic eccrine hidradenitis (NEH) is a neutrophilic dermatosis primarily affecting the eccrine glands and occurs most commonly in patients undergoing chemotherapy for a malignancy. (annals.edu.sg)